research Self-Reported Hair Loss Following COVID-19: An Observational Study
Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.
Search
for
Sort by
Research
180-210 / 1000+ results 
research Telogen Effluvium and COVID-19: A Case and a Brief Review of Literature
COVID-19 may cause temporary hair loss due to the body's immune response.
research Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Can The Golden Nutraceutical Frankincense Combat COVID-19?
Frankincense may help treat COVID-19, but more research is needed.
research Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From COVID-19
More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.
research Hormonal Trends in Patients Suffering from Long COVID Symptoms
Long COVID patients may have hormonal imbalances linked to their symptoms.
research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations
COVID-19 infection may trigger alopecia areata in some patients.
research COVID-19 Induced Telogen Effluvium
COVID-19 may cause temporary hair loss in some people.
research Covid Induced Telogen Effluvium: An Insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.
research Data-Driven Analysis to Understand Long COVID Using Electronic Health Records From the RECOVER Initiative
Long COVID patients have more health issues than non-infected people.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research Dermatologic Changes in Experimental Model of Long COVID
Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.
research Telogen Effluvium Post-COVID: An Integrative Review
COVID-19 can cause temporary hair loss.
research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19
A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.
research The Immune Response to COVID-19: Does Sex Matter?
Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.
research Prevalence of Long COVID Syndrome and Its Association With Blood Group: A Cross-Sectional Study
Long COVID is more common in those with severe initial infections, but not linked to blood group.
research Regenerative Potential and Clinical Application of Mesenchymal Stem Cell-Derived Exosomes
MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.
research The Necessity of Investigations to Clarify Sex and Racial Disparities in Pathophysiology of Long COVID
More research is needed to understand sex and racial differences in long COVID.
research Long COVID? What Is That?
Long COVID is a serious, long-lasting illness that needs more recognition and support.
research Corona With Lyme: A Long COVID Case Study
The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.
research Risk Factors and Early Preventive Measures for Long COVID in Non-Hospitalized Patients: Analysis of a Large Cohort in the United Arab Emirates
Vaccination and timely treatment reduce the risk of long COVID.
research Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects
COVID-19 can cause a temporary hair loss condition.
research Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-Sectional Observational Study
Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.
research Telogen Effluvium as a Symptom of Long Covid in Pre-Infected SARS-CoV-2 Patients: An Integrative Literature Review
Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.
research A Case of Severe Autoimmune Hemolytic Anemia After Receipt of First Dose of SARS-CoV-2 Vaccine
An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.
research The Clinical Course and Outcomes of SARS-CoV-2 Virus Infection in Children: A 24-Week Follow-Up Study in Sulaimaniyah, Iraq
Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.
research Red LED Light Therapy for Telogen Effluvium in Long COVID Patients With and Without Androgenetic Alopecia
Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.
research Sex Hormones in SARS-CoV-2 Susceptibility: Key Players or Confounders?
Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.
research Persistence of Long-COVID Symptoms in a Heterogeneous Prospective Cohort
Long-COVID symptoms can last more than a year and change over time.